Are you Dr. Edgerton?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2001 2nd Ave
Ste 201
Summerville, SC 29486Phone+1 843-572-4840Fax+1 843-793-6156
Summary
- Dr. Colin Edgerton, MD is a rheumatologist in Summerville, South Carolina. He is currently licensed to practice medicine in South Carolina and Nebraska.
Education & Training
- National Capital ConsortiumFellowship, Rheumatology, 2004 - 2006
- Madigan Army Medical CenterResidency, Internal Medicine, 2001 - 2004
- Georgetown University School of MedicineClass of 2001
Certifications & Licensure
- SC State Medical License 2012 - 2025
- NE State Medical License 2003 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Start of enrollment: 2015 Feb 21
Publications & Presentations
PubMed
- Real-World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First-Line Tumor Necrosis Factor Inhibitor Therapy in the United States.Colin Edgerton, Andrew Frick, Simon Helfgott, Kent Kwas Huston, Jasvinder A Singh
ACR Open Rheumatology. 2024-04-01 - 40 citations60 kD Ro and nRNP A Frequently Initiate Human Lupus AutoimmunityLatisha Heinlen, Micah T. McClain, Lauren L. Ritterhouse, Benjamin F. Bruner, Colin C. Edgerton
Plos One. 2010-03-10 - 74 citationsIL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone miceColin Edgerton, José C. Crispín, Chantal Moratz, Estelle Bettelli, Mohamed Oukka
Clinical Immunology. 2009-03-01
Press Mentions
- Osteoporosis and Diabetes: What You Need to KnowDecember 22nd, 2022
- Gout and Type 2 Diabetes: Why You’re at Increased RiskDecember 30th, 2021
- ACR Leads AMA Resolution on Payer Financial Incentives to Patients to Switch TreatmentMay 22nd, 2021
- Join now to see all
Professional Memberships
- Fellow